Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Azithromycin clinical pharmacokinetics

N J Lalak1, D L Morris

  • 1Department of Surgery, St George Hospital, Sydney, New South Wales, Australia.

Clinical Pharmacokinetics
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of lysophospholipids on short-term production, nitrogen utilization, and rumen fermentation and bacterial population in lactating dairy cows.

Journal of dairy science·2019
Same author

Validating and optimizing spot sampling of urine to estimate urine output with creatinine as a marker in dairy cows.

Journal of dairy science·2018
Same author

Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2018
Same author

The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI).

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2018
Same author

Validating intrinsic markers and optimizing spot sampling frequency to estimate fecal outputs.

Journal of dairy science·2018
Same author

Effects of corn feeding reduced-fat distillers grains with or without monensin on nitrogen, phosphorus, and sulfur utilization and excretion in dairy cows.

Journal of dairy science·2018
Same journal

Population Pharmacokinetic Modelling of Dolutegravir: A Narrative Review.

Clinical pharmacokinetics·2026
Same journal

Partial Area Under the Curve: A Revelatory Story in Pharmacokinetics.

Clinical pharmacokinetics·2026
Same journal

Informing Sampling Design for Lung Distribution Studies Using a Pulmonary Population Minimal PBPK Model.

Clinical pharmacokinetics·2026
Same journal

Revisited Pharmacokinetic Profiles of Methylprednisolone in Plasma and Urine After Single and Multiple Oral Administrations: Relevance in Sports Drug Testing.

Clinical pharmacokinetics·2026
Same journal

ALBI Grade is a Determinant of Lenvatinib Pharmacokinetics, Efficacy, and Toxicities in Japanese Patients with Hepatocellular Carcinoma.

Clinical pharmacokinetics·2026
Same journal

Quantitative Pharmacology Justifying Ribociclib Dose in Early Breast Cancer.

Clinical pharmacokinetics·2026
See all related articles

Azithromycin, a novel azalide antibiotic, shows unique pharmacokinetic properties, distributing rapidly into tissues and cells. This allows for sustained drug concentrations at infection sites, enhancing its therapeutic potential.

Area of Science:

  • Pharmacology
  • Microbiology
  • Infectious Diseases

Background:

  • Azalide antibiotics represent a distinct class with unique pharmacokinetic profiles compared to traditional antibiotics.
  • Azithromycin is the first clinically utilized azalide antibiotic.

Purpose of the Study:

  • To elucidate the pharmacokinetic properties of azithromycin.
  • To understand its distribution and concentration in various tissues and cellular compartments.
  • To correlate pharmacokinetic data with therapeutic efficacy.

Main Methods:

  • Pharmacokinetic analysis of azithromycin.
  • Measurement of drug concentrations in serum, tissues, and intracellular compartments.
  • Dosing regimen evaluation (500mg day 1, then 250mg daily days 2-5).

Related Experiment Videos

Main Results:

  • Azithromycin exhibits approximately 37% bioavailability.
  • Rapid and extensive distribution from serum into intracellular compartments and tissues.
  • Tissue concentrations can reach up to 100-fold higher than serum concentrations post-dose.
  • High concentrations are achieved in tonsils, lungs, prostate, lymph nodes, and liver.
  • Sustained drug levels at infection sites are maintained for several days after cessation of administration.

Conclusions:

  • Azithromycin's unique pharmacokinetics, particularly its intracellular concentration within phagocytes, contribute to its efficacy against infections.
  • The drug's distribution pattern and sustained tissue levels support its diverse therapeutic applications.
  • The established dosing regimen ensures prolonged therapeutic drug concentrations.